BOSULIF is indicated for the treatment of adult patients with1:
Log in/register to download the CML checklist; a resource for HCPs to aid discussions with patients on disease status and wider comorbidities that could impact treatment decisions.
A summary of current considerations in the management of CML presented by Prof Adam Mead, including baseline characteristics assessment and patient monitoring for first-line treatment, as well as considerations for second-line treatment.
Download key fact sheet explaining BOSULIF's mode of action in CML, key BYOND and BFORE data, dosing and guidelines recommendations.
Watch on-demand videos exploring the CML landscape and key considerations in the management of patients with CML
Download materials supporting you with the use of BOSULIF and managing patients with CML
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021